Follow
Gourav Rakshit
Gourav Rakshit
PhD Scholar
Verified email at bitmesra.ac.in
Title
Cited by
Cited by
Year
Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies
M Rudrapal, WA Eltayeb, G Rakshit, AA El-Arabey, J Khan, SM Aldosari, ...
Scientific reports 13 (1), 8656, 2023
332023
Flavonoids as potential therapeutics against novel coronavirus disease-2019 (nCOVID-19)
G Rakshit, P Dagur, S Satpathy, A Patra, A Jain, M Ghosh
Journal of Biomolecular Structure and Dynamics 40 (15), 6989-7001, 2022
212022
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: Where we stand
M Shyam, D Shilkar, G Rakshit, V Jayaprakash
Expert opinion on drug discovery 17 (7), 699-715, 2022
162022
Tuberculosis and HIV responses threatened by nCOVID-19: A situation prompting an in silico investigation of reported MbtA inhibitors for combined inhibition of …
G Rakshit, V Jayaprakash
Structural Chemistry 34 (2), 655-679, 2023
72023
Target prediction, computational identification, and network-based pharmacology of most potential phytoconstituent in medicinal leaves of Justicia adhatoda against SARS-CoV-2
P Dagur, G Rakshit, M Sheikh, A Biswas, P Jha, K Al-Khafaji, M Ghosh
Journal of Biomolecular Structure and Dynamics 41 (9), 3926-3942, 2023
32023
Molecular docking and molecular dynamics in natural products-based drug discovery
G Rakshit, P Dagur, A Biswas, S Murtuja, V Jayaprakash
Phytochemistry, computational tools and databases in drug discovery, 195-212, 2023
32023
In Silico Drug Repurposing Studies for the Discovery of Novel Salicyl-AMP Ligase (MbtA) Inhibitors
G Rakshit, A Biswas, V Jayaprakash
Pathogens 12 (12), 1433, 2023
22023
Virtual screening of phytochemicals for drug discovery
P Dagur, G Rakshit, M Ghosh
Phytochemistry, Computational Tools and Databases in Drug Discovery, 149-179, 2023
22023
Structure-based drug design (SBDD)
G Rakshit, S Murtuja, BK Kumar, S Murugesan, V Jayaprakash
Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure …, 2022
22022
Computational Simulations Reveal the Synergistic Action of Phytochemicals of Morus alba to Exert Anti-Alzheimer Activity via Inhibition of Acetylcholinesterase and …
A Paul, JH Zothantluanga, G Rakshit, I Celik, M Rudrapal, MK Zaman
Polycyclic Aromatic Compounds, 1-25, 2023
12023
Design, Development, and In Silico Study of Pyrazoline-Based Mycobactin Analogs as Anti-Tubercular Agents
G Rakshit, S Murtuja, V Jayaprakash
Chemistry Proceedings 8 (1), 62, 2021
12021
Synthesis of thiadiazole derivatives as competitive inhibitors of α-glucosidase and tyrosinase
U Ghani, UA Çevik, M Rudrapal, G Rakshit, ZA Kaplancıklı
Journal of Molecular Structure 1307, 138028, 2024
2024
Design, synthesis, biological and computational screening of novel pyridine-based thiadiazole derivatives as prospective anti-inflammatory agents
N Podila, NK Penddinti, M Rudrapal, G Rakshit, SK Konidala, VS Pulusu, ...
Heliyon, 2024
2024
Dietary Polyphenols: Review on Chemistry/Sources, Bioavailability/Metabolism, Antioxidant Effects, and Their Role in Disease Management
M Rudrapal, G Rakshit, RP Singh, S Garse, J Khan, S Chakraborty
Antioxidants 13 (4), 429, 2024
2024
New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
UA Çevik, B Kaya, I Celik, M Rudrapal, G Rakshit, A Karayel, S Levent, ...
ACS omega 9 (11), 13359-13372, 2024
2024
In Silico Drug Re-Purposing Studies for the Discovery of Novel MbtA Inhibitors
G Rakshit, A Biswas, V Jayaprakash
Preprints, 2023
2023
Multi-Omics Approaches in Drug Discovery
G Rakshit, Komal, P Dagur, V Jayaprakash
CADD and Informatics in Drug Discovery, 79-98, 2023
2023
Application of artificial intelligence and machine learning in natural products-based drug discovery
A Biswas, I Ghosh, G Rakshit, S Murtuja, P Dagur, V Jayaprakash
Phytochemistry, Computational Tools and Databases in Drug Discovery, 335-355, 2023
2023
Designing and In Silico Evaluation of Some Non-Nucleoside MbtA Inhibitors: On Track to Tackle Tuberculosis
G Rakshit, V Jayaprakash
Chemistry Proceedings 12 (1), 78, 2022
2022
Design and In Silico Evaluation of Some Non-Nucleoside MbtA Inhibitors (Pyrazoline Based Mycobactin Analogs) as Anti-Tubercular Agents: On Track to Tackle Tuberculosis
G Rakshit, V Jayaprakash
MDPI, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20